http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008137699-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4c1cb0ae17becbc0868b3ce2ca0dd8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_649cb7e8c02a51a09b165804c0342ec4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-90
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42
filingDate 2008-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2e332e2d96bde74355d219f7a2212bc
publicationDate 2009-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008137699-A3
titleOfInvention Topical formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice with multiple modes of action
abstract Topical formulations for prophylaxis or elimination of susceptible and treatment resistant head lice wherein the formulation is an aqueous dispersion of an oil phase containing an effective amount of an active ingredient component combining at least one compound that binds to glutamate-gated chloride ion channels and at least one compound that binds to gamma-amino butyric acid (GABA) receptors, dissolved in at least one water- soluble or water-miscible surface active agent with one or more suspending agents and one or more non-ionic surfactants. Also disclosed are methods of using the topical formulations to treat or prevent an infestation of either a susceptible or treatment resistant strain of head lice in a human patient.
priorityDate 2007-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006140995-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003149090-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005276763-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004097377-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005000241-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007020304-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID121225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID121225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487869

Total number of triples: 26.